KL-6 in serum as a biomarker for differentiation of chronic allograft dysfuntion in lung transplant. Preliminary results

Cristina Berastegui (Barcelona, Spain), Cristina Berastegui, Susana Gomez-Olles, Alberto Mendoza-Valderrey, Berta Sáez-Gimenez, Manuel López-Meseguer, Carlos Bravo-Masgoret, Mario Culebras, Victor Monforte, Antonio Roman

Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Session: Post-transplant complications: from animal models to the bedside
Session type: Poster Discussion
Number: 4638

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Cristina Berastegui (Barcelona, Spain), Cristina Berastegui, Susana Gomez-Olles, Alberto Mendoza-Valderrey, Berta Sáez-Gimenez, Manuel López-Meseguer, Carlos Bravo-Masgoret, Mario Culebras, Victor Monforte, Antonio Roman. KL-6 in serum as a biomarker for differentiation of chronic allograft dysfuntion in lung transplant. Preliminary results. Eur Respir J 2016; 48: Suppl. 60, 4638

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Mechanistical differences of chronic lung allograft dysfunction phenotypes in lung transplantation
Source: Annual Congress 2012 - Novel approaches to lung transplantation
Year: 2012

Evaluation of lung mechanics and the progression of disease in acute allograft rejection after lung transplantation
Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation
Year: 2010

Breath VOC patterns of lung transplant recipients with and without chronic lung allograft dysfunction (CLAD)
Source: International Congress 2017 – Chronic airway disease: markers of disease impact
Year: 2017

Lung ultrasound to phenotype chronic lung allograft dysfunction in lung transplant recipients. A prospective observational study.
Source: Virtual Congress 2021 – Thoracic ultrasound: future applications and current evidence
Year: 2021



Pleural fluid cytokines after lung transplantation as markers of acute rejection development
Source: Annual Congress 2010 - Current issues in malignant pleural diseases
Year: 2010


Oxygenated hemoglobin predicts outcome in patients with chronic lung allograft dysfunction
Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward?
Year: 2021



Electronic nose for detecting chronic lung allograft dysfunction in lung transplant recipients
Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward?
Year: 2021



Immunophenotype and gene signature of long-term survivors with normal allograft function after lung transplantation
Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes
Year: 2019

Extracorporeal photoapheresis in the treatment of chronic lung rejection: preliminary clinical and immunological results on a small cohort of lung recipients
Source: Annual Congress 2008 - New insights and treatment options for bronchiolitis obliterans syndrome after lung transplantation
Year: 2008

A new biomarker for chronic lung allograft dysfunction
Source: International Congress 2014 – Chronic lung allograft dysfunction: mechanisms, predictors and phenotypes
Year: 2014

Plasma CRP levels correlate with markers of airway inflammation after lung transplantation: a role for systemic inflammation in bronchiolitis obliterans syndrome?
Source: Annual Congress 2008 - New insights and treatment options for bronchiolitis obliterans syndrome after lung transplantation
Year: 2008



Multi-omics profiling predicts allograft function after lung transplantation
Source: Eur Respir J, 59 (2) 2003292; 10.1183/13993003.03292-2020
Year: 2022



Prognostic factors in patients with end stage idiopathic pulmonary fibrosis awaiting lung transplantation
Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings
Year: 2009


Lung volumes predict survival in patients with chronic lung allograft dysfunction
Source: Eur Respir J , 49 (4)  1601315; DOI: 10.1183/13993003.01315-2016
Year: 2017



KL-6 is a useful serum biomarker for early detection of interstitial lung disease
Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities
Year: 2012


Prognostic value of cardiac and lung abnormalities in hepatic transplant recipients
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010

Pathophysiology of the lung allograft: pathways of graft rejection
Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients
Year: 2005


Lung function tests and survival in idiopathic pulmonary fibrosis after lung transplantation
Source: Eur Respir J 2005; 26: Suppl. 49, 335s
Year: 2005

CT findings before and after azithromycin treatment of chronic lung allograft dysfunction
Source: Annual Congress 2011 - Improving outcomes after lung transplantation
Year: 2011

A model of chronic lung allograft rejection in the rat
Source: Eur Respir J 2010; 35: 1354-1363
Year: 2010